Sovarnum Capital’s Merck MRK Stock Holding History

Sovarnum Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-29,763	Closed	-$1.6M	–	109
2017 Q4	$1.6M	Buy	+29,763	New	+$1.65M	1.08%	28

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sovarnum Capital's MRK Position: Q1 2018 in Review

Sovarnum Capital sold out of Merck (MRK) in Q1 2018, closing a stake of 12,960 shares — an estimated $696K sold.

Sovarnum Capital first reported a position in MRK in Q4 2017 and held it in 1 quarter. The position peaked at $696K in Q4 2017. 1,992 funds tracked by Wall St. Rank hold MRK as of Q1 2018.

Sovarnum Capital reported no remaining Merck position as of Q1 2018 after selling out during the quarter.
Sovarnum Capital sold 12,960 Merck shares in Q1 2018, an estimated $696K.
Sovarnum Capital first reported a position in Merck in Q4 2017 and held it in 1 quarter.
Sovarnum Capital's Merck position peaked at $696K in Q4 2017.
1,992 funds tracked by Wall St. Rank held Merck as of Q1 2018.

Based on Sovarnum Capital's 13F filing for Q1 2018, filed 14 May 2018.